NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
CrisisInfrastructureStrikesIranTrumpNuclearFebruaryNewsMilitaryReachedLimitedDigestTimelineTrump'sDaysAnnounceDailyTariffsProtestsGreenlandChallengeEuropeanLongevityEmergency
CrisisInfrastructureStrikesIranTrumpNuclearFebruaryNewsMilitaryReachedLimitedDigestTimelineTrump'sDaysAnnounceDailyTariffsProtestsGreenlandChallengeEuropeanLongevityEmergency
All Articles
Alison Roman’s Plan to Conquer the Tomato Sauce Market
Bloomberg
Published about 2 hours ago

Alison Roman’s Plan to Conquer the Tomato Sauce Market

Bloomberg · Feb 23, 2026 · Collected from RSS

Summary

Alison Roman is a cult figure in the world of food media. Now she's putting her name on consumer goods, recently launching a new line of high-end jarred tomato sauce called, appropriately, A Very Good Sauce. Alison Roman joins Tracy Alloway and Joe Weisenthal on the Odd Lots podcast to discuss what she's learned about the consumer goods industry, from shipping to co-packing to designing a recipe that can be cooked in high volume. (Source: Bloomberg)

Share this story
Read Original at Bloomberg

Related Articles

Bloombergabout 1 hour ago
US Factory, Durable Goods Orders Declined in December

US Factory orders fell 0.7% in December, US Census Bureau data show, while durable goods orders were down 1.4%. Michael McKee reports on Bloomberg Television. (Source: Bloomberg)

Bloombergabout 1 hour ago
Italy’s F2i Fund Nears €1 Billion on Europe Infrastructure Push

F2i SGR, Italy’s largest independent infrastructure fund manager, brought its credit assets close to €1 billion ($1.2 billion) as demand grows for private financing to modernize European infrastructure.

Bloombergabout 2 hours ago
Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly’s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks on "Bloomberg Open Interest." (Source: Bloomberg)

Bloombergabout 2 hours ago
Colombia Hawkish Pivot Masks Underlying Woes for Peso

Colombia’s peso is defying economic and political woes after a surprisingly hawkish pivot in monetary policy reinforced the dominant carry trade.

Bloombergabout 2 hours ago
S&P 500 Falls on Tariff Questions, Nvidia Gains Before Earnings

US stocks traded lower on Monday as President Donald Trump responded to the Supreme Court’s ruling against his sweeping tariffs by imposing a new, across-the-board 15% levy on US imports, sowing fresh confusion around global trade. Shares of Nvidia Corp. were a bright spot, advancing before Wednesday’s earnings report.

Bloombergabout 2 hours ago
Market Reaction to Tariffs Subdued, BMO CEO Says

Market reaction to the US Supreme Court ruling on tariffs has been subdued, said Bank of Montreal Chief Executive Officer Darryl White. “Part of that is because some of the outcome that we saw over the last few days was probably priced into bond markets, so we haven’t seen much of a reaction there,” he said on Bloomberg Surveillance. (Source: Bloomberg)